Here is a complete, easy-to-understand guide to CNS pharmacology, built from Katzung's Basic & Clinical Pharmacology (16th ed.).
CNS Pharmacology - A Simple, Structured Guide
The Big Idea: One Mental Model to Rule Them All
Every CNS drug does one (or more) of these things at a synapse:
- Mimics a neurotransmitter (agonist)
- Blocks a neurotransmitter receptor (antagonist)
- Increases neurotransmitter availability (blocks reuptake, blocks breakdown, stimulates release)
- Decreases neurotransmitter availability (blocks synthesis, blocks release, depletes stores)
- Modulates downstream signaling (second messengers, ion channels)
If you always ask "which transmitter, and what is the drug doing to it?" - you can figure out almost any CNS drug's effects and side effects.
Step 1: Understand the Basic Wiring
The Neuron and Synapse
A neuron has dendrites (receive signals), a cell body, and an axon (sends signals). The axon is wrapped in myelin (made by oligodendrocytes). At the synapse, the signal is chemical:
- Action potential arrives at axon terminal
- Voltage-gated Ca²+ channels open → Ca²+ flows in
- Vesicles fuse, releasing neurotransmitter into the synaptic cleft
- Neurotransmitter binds postsynaptic receptor
- Signal is terminated by reuptake or enzymatic degradation
Why this matters for drugs: Drugs can interfere at every single one of these steps.
- Katzung's Basic and Clinical Pharmacology, 16th Ed., p. 577-584
The Blood-Brain Barrier (BBB) - The Gatekeeper
A key reason CNS drugs are hard to design. Tight junctions between brain capillary endothelial cells, surrounded by astrocyte end-feet, block most drugs. To get into the CNS a drug must be:
- Highly lipid-soluble (lipophilic), OR
- Use a specific transporter
Classic example: Dopamine can't cross the BBB, but L-DOPA can (uses an amino acid transporter). So L-DOPA is given in Parkinson's disease, not dopamine itself.
Step 2: Understand the Two Receptor Types
| Feature | Ionotropic (Ligand-gated) | Metabotropic (GPCRs) |
|---|
| Speed | Fast (milliseconds) | Slow (seconds-minutes) |
| Mechanism | NT binds → ion channel opens directly | NT binds → G-protein → 2nd messengers |
| Examples | GABA-A, NMDA, nicotinic ACh | GABA-B, dopamine, serotonin (most), mAChR |
| Drug targets | Benzodiazepines, ketamine | Antipsychotics, antidepressants, opioids |
Easy trick: Ionotropic = "Instant." Metabotropic = "Meandering (slow)."
Step 3: Learn the 6 Key Neurotransmitter Systems
This is the heart of CNS pharmacology. Each system = a cluster of drugs.
1. GABA - The Brain's Brake Pedal
- Role: Main inhibitory transmitter. When GABA is active, the neuron is less likely to fire.
- Receptor: GABA-A (ionotropic, Cl⁻ channel) | GABA-B (metabotropic)
- Drugs:
- Benzodiazepines (diazepam, lorazepam): Enhance GABA-A → more Cl⁻ enters → more inhibition → sedation/anxiolysis/anticonvulsant
- Barbiturates (phenobarbital): Similar, but higher overdose risk
- Alcohol: Also enhances GABA-A
- Vigabatrin: Blocks GABA breakdown → more GABA available (anticonvulsant)
- Memory hook: "GABA = Calm down. Drugs that boost GABA = calm/sedate. Drugs that block GABA = seizures."
2. Glutamate - The Gas Pedal
- Role: Main excitatory transmitter. Fires neurons.
- Receptors: AMPA (fast, Na+), NMDA (slow, Ca²+, needs glycine co-agonist), metabotropic
- Drugs:
- Ketamine/Memantine: Block NMDA channel pore → anesthesia/anti-Alzheimer
- Lamotrigine: Blocks Na+ channels, reduces glutamate release → anticonvulsant
- Memory hook: "Glutamate = Go. Block it = less excitation = fewer seizures, less pain, anesthesia."
3. Dopamine - The Reward & Movement System
- Pathways:
- Nigrostriatal (SN → striatum): movement - loss causes Parkinson's
- Mesolimbic (VTA → limbic system): reward/pleasure - excess = psychosis
- Mesocortical (VTA → prefrontal cortex): cognition/motivation
- Tuberoinfundibular (hypothalamus → pituitary): prolactin regulation
- Drugs:
- L-DOPA: Dopamine precursor for Parkinson's (restores nigrostriatal dopamine)
- Antipsychotics (haloperidol, risperidone): Block D2 receptors → reduces psychosis. Block nigrostriatal D2 → extrapyramidal side effects. Block tuberoinfundibular D2 → hyperprolactinemia.
- Amphetamine/cocaine: Increase dopamine → euphoria, addiction
- Memory hook: "Dopamine - the 4 pathways decide all antipsychotic side effects."
4. Serotonin (5-HT) - Mood, Sleep, Appetite
- Origin: Raphe nuclei in brainstem → projects almost everywhere
- Drugs:
- SSRIs (fluoxetine, sertraline): Block serotonin reuptake transporter → more 5-HT at synapse → treats depression/anxiety
- SNRIs (venlafaxine): Block both serotonin AND norepinephrine reuptake
- Triptans (sumatriptan): 5-HT1B/1D agonists → treat migraine
- Ondansetron: 5-HT3 antagonist → antiemetic
- Buspirone: 5-HT1A partial agonist → anxiolytic
- Memory hook: "Serotonin runs from the raphe to everywhere. SSRIs block its reuptake = more available."
5. Norepinephrine (NE) - Arousal & Attention
- Origin: Locus coeruleus → projects broadly
- Drugs:
- SNRIs/TCAs: Block NE reuptake → antidepressant
- Atomoxetine: Selective NE reuptake inhibitor → ADHD
- Clonidine: Alpha-2 agonist → reduces NE release → lowers BP, treats ADHD/withdrawal
- Beta-blockers (propranolol): Block peripheral beta receptors → reduce performance anxiety
6. Acetylcholine (ACh) - Memory, Arousal, Muscle Control
- Receptors:
- Muscarinic (mAChR): CNS (memory, arousal), autonomic
- Nicotinic (nAChR): Neuromuscular junction, autonomic ganglia, CNS reward
- Drugs:
- Donepezil/Rivastigmine: Block acetylcholinesterase → more ACh → treats Alzheimer's
- Atropine: Muscarinic antagonist → blocks CNS and peripheral ACh
- Nicotine: nAChR agonist → stimulant, addiction
- Memory hook: "ACh = Memory. Block ACh in brain = confused/forgetful (anticholinergic side effects in elderly)."
Step 4: Where Drugs Act - Presynaptic vs Postsynaptic
| Location | Mechanism | Example |
|---|
| Presynaptic - synthesis block | Reduces transmitter made | AMPT (blocks catecholamine synthesis) |
| Presynaptic - storage block | Depletes vesicles | Reserpine (depletes monoamines) |
| Presynaptic - release block | Stops exocytosis | Tetanus toxin |
| Presynaptic - release stimulation | Floods synapse | Amphetamine (releases catecholamines) |
| Presynaptic - reuptake block | More NT in cleft | Cocaine, SSRIs, TCAs |
| Presynaptic - enzyme block | More NT in terminal | MAO inhibitors (more monoamines) |
| Postsynaptic - agonist | Mimics NT | Opioids (mimic enkephalin), L-DOPA |
| Postsynaptic - antagonist | Blocks NT action | Antipsychotics (block D2) |
| Ion channel - direct block | Blocks channel pore | Ketamine (NMDA), phenytoin (Na+) |
- Katzung's Basic and Clinical Pharmacology, 16th Ed., p. 583-584
Step 5: Quick Disease-Drug Mapping
| Disease | Main Transmitter Imbalance | Drug Approach |
|---|
| Depression | Low serotonin + NE | SSRI, SNRI, TCA, MAOI |
| Anxiety | Low GABA | Benzodiazepines, buspirone, SSRIs |
| Schizophrenia | Excess dopamine (mesolimbic) | D2 blockers (antipsychotics) |
| Parkinson's | Low dopamine (nigrostriatal) | L-DOPA, dopamine agonists |
| Alzheimer's | Low ACh | Acetylcholinesterase inhibitors |
| Epilepsy | Excess glutamate OR low GABA | Enhance GABA (benzos, valproate) / Block Na+ (phenytoin) / Block glutamate (NMDA block) |
| ADHD | Low dopamine + NE (prefrontal) | Methylphenidate, amphetamine, atomoxetine |
| Pain (opioid) | Opioid receptors (MOR, KOR) | Morphine, codeine |
Study Tips for CNS Pharmacology
-
Draw the synapse once - label every step (synthesis → storage → release → receptor → reuptake → degradation). Then place drugs at each step. This one diagram explains 80% of CNS drug mechanisms.
-
Group by transmitter, not by drug class - Don't study "antidepressants" as a list. Study "what happens when you increase serotonin?" and the drug names follow naturally.
-
Learn side effects from mechanism - Antipsychotics block D2 everywhere, so: nigrostriatal = EPS, tuberoinfundibular = elevated prolactin, mesolimbic = antipsychotic effect. No memorization needed.
-
Use the BBB as a filter - Always ask "can this drug enter the brain?" Lipophilic = yes. Polar = no. Second-generation antihistamines are polar on purpose to avoid sedation.
-
Ionotropic = fast drugs (acute use), Metabotropic = slow drugs (chronic use) - Benzodiazepines (GABA-A, ionotropic) work in minutes. SSRIs (metabotropic pathway changes) take 2-4 weeks. This explains clinical timing.
-
Retrograde signaling - Remember endocannabinoids go backwards (postsynaptic → presynaptic), which is why cannabis has unique effects. This is pharmacologically distinct from all other transmitters.
Source: Katzung's Basic and Clinical Pharmacology, 16th Edition, Chapter 21 - Introduction to the Pharmacology of CNS Drugs (p. 577-590)